Keryx (KERX) Reports Q4 Loss of 9c, Misses by 3c
Tweet Send to a FriendGet Alerts KERX Hot Sheet
Price: $8.04 +0.50%
EPS Growth %: +76.9%
Financial Fact:
Total operating expenses: 9.16M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +76.9%
Financial Fact:
Total operating expenses: 9.16M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade KERX Now!
Keryx Biopharma (Nasdaq: KERX) reports Q4 loss of 9c, vs. the consensus of a 6c loss.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
